
What Are Myelodysplastic Syndromes (MDS)? - American Cancer Society
Myelodysplastic syndromes (MDS), also known as myelodysplastic neoplasms, are conditions that can occur when the blood-forming cells in the bone marrow become abnormal, resulting in the marrow …
Myelodysplastic syndromes - Symptoms and causes - Mayo Clinic
Oct 25, 2024 · Myelodysplastic syndromes are a group of disorders caused by blood cells that are poorly formed or don't work properly. Myelodysplastic syndromes result from something amiss in the …
Myelodysplastic Syndrome (MDS): Symptoms, Diagnosis & Treatment
Jul 10, 2023 · If you have myelodysplastic syndrome (MDS), you have a form of cancer that’s a chronic illness. No illness is easy, but having a chronic illness means also managing the emotional impact of …
Myelodysplastic Syndromes (MDS): Causes, Symptoms, Treatment
Nov 21, 2024 · Myelodysplastic syndromes (MDS) are a rare group of disorders in which your body no longer makes enough healthy blood cells. With MDS, your bone marrow cells become abnormal and …
Myelodysplastic Syndromes Treatment - NCI - National Cancer Institute
Oct 4, 2024 · Myelodysplastic syndromes (MDS) treatment options include supportive care, drug therapy, and chemotherapy with allogeneic stem cell transplant. Learn more about newly diagnosed …
What is MDS? | MDS Foundation
Myelodysplastic syndromes (MDS) are an often unrecognized, under-diagnosed, rare group of bone marrow failure disorders, where the body no longer makes enough healthy, normal blood cells in the …
What to Know About Myelodysplastic Syndromes (MDS)
Dec 3, 2025 · Myelodysplastic syndromes (MDS) are a group of blood cancers that interfere with your body’s ability to make healthy blood cells. Treatment can help manage it.
Myelodysplastic Syndrome (MDS) - Boston Children's Hospital
Myelodysplastic syndrome (MDS) is a rare disease of the blood, only occurring in four out of every 1 million children. While it develops in older patients (greater than 60 years old) most of the time, it can …
Myelodysplastic syndromes (MDS) | Blood Cancer United
Myelodysplastic syndromes (MDS) are a group of cancers that affect blood and bone marrow, with varying degrees of severity, treatments, and life expectancy.
Phase III VERONA trial results show potential benefit for some groups ...
6 days ago · Based on that rationale, Garcia led a phase 1b trial investigating treatment of newly diagnosed patients with high-risk MDS with venetoclax plus azacitidine. That trial showed promising …